Our partner is focused on developing innovative therapies for thyroid eye disease and other autoimmune conditions. Their approach aims to address the underlying immune system mechanisms, with the goal of improving patient outcomes and providing more effective treatments for these challenging diseases.

This critical hire built and managed a high-growth pharmacovigilance team and management systems. They collaborated with QA teams on SOPs and processes to achieve inspection readiness in preparation for BLA filing. Additionally, they oversaw CROs and reports for three assets in global trials.